BioMed Research International
Volume 2020 (2020), Article ID 8493938, 3 pages
https://doi.org/10.1155/2020/8493938

Erratum

Erratum to “An Inhibitor of DRP1 (Mdivi-1) Alleviates LPS-Induced Septic AKI by Inhibiting NLRP3 Inflammasome Activation”

Ruijin Liu,¹ Si-cong Wang,¹ Ming Li,² Xiao-hui Ma,³ Xiao-nan Jia,³ Yue Bu,¹ Lei Sun,¹ and Kai-jiang Yu3,4

¹Department of Critical Care Medicine, The Harbin Medical University Cancer Hospital, Harbin, 150081 Heilongjiang Province, China
²Department of Critical Care Medicine, The Second Affiliated Hospital of Harbin Medical University, Harbin, 150081 Heilongjiang Province, China
³Department of Critical Care Medicine, The First Affiliated Hospital of Harbin Medical University, Harbin, 150001 Heilongjiang Province, China
⁴Institute of Critical Care Medicine and Institute of Sino Russian Medical Research Center of Harbin Medical University, 150 Hapin Road, Harbin 150081, China

Correspondence should be addressed to Kai-jiang Yu; yukaijiangicu@163.com

Received 22 August 2020; Accepted 24 August 2020; Published 19 September 2020

Copyright © 2020 Ruijin Liu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

In the article titled “An Inhibitor of DRP1 (Mdivi-1) Alleviates LPS-Induced Septic AKI by Inhibiting NLRP3 Inflammasome Activation” [1], the published version of Figure 4(a) was a duplicate of Figure 2(a). This mistake was introduced during the production of the article, and the publisher apologises for this error.

The corrected figure is shown below and is listed as Figure 1.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

Figure 1: S-AKI cell model shows that DRP1 inhibition attenuates renal tubular epithelial pyroptosis and protects mitochondrial function by NLRP3 inflammasome pathway protein expression downregulation. (a) Western blot protein expression bands of the NLRP3 inflammasome-related proteins, NLRP3, GSDMD, cl. caspase-1, IL-1β, and IL-18. (b) Semiquantitative analysis of Western blot protein expression bands of the NLRP3 inflammasome-related proteins. (c) JC-1 staining of cells, where the color red represents the membrane potential level. Image obtained under a confocal microscope (20x magnification). (d) MitoSOX staining of cells, where the color red represents the superoxidation level. Image obtained under a confocal microscope (60x magnification). (e) Quantitative analysis of JC-1 staining. (f) Quantitative analysis of MitoSOX staining. (g) Intracellular ATP levels in different treatment groups. for each group in all experiments. The data are presented as . versus control-treated cells. # versus LPS-treated cells in the absence of Mdivi-1 treatment.

References

R. Liu, S.-c. Wang, M. Li et al., “An inhibitor of DRP1 (Mdivi-1) alleviates LPS-induced septic AKI by inhibiting NLRP3 inflammasome activation,” BioMed Research International, vol. 2020, Article ID 2398420, 11 pages, 2020.